3 Year Absolute Returns
84.51% ↑
NAV (₹) on 18 Jun 2026
46.12
1 Day NAV Change
0.51%
Risk Level
Very High Risk
Rating
-
DSP Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by DSP Investment Managers Pvt. Ltd.. Launched on 12 Nov 2018, investors can start with a lumpsum investment ... Read more
AUM
₹ 3,309.17 Cr
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 61.44% |
| Foreign Securities | 17.13% |
| Hospitals & Medical Services | 12.72% |
| Treps/Reverse Repo | 6.47% |
| Finance - Non Life Insurance | 1.31% |
| International Mutual Fund Units | 0.88% |
| Medical Equipment & Accessories | 0.20% |
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 8.79% | ₹ 266.73 | Pharmaceuticals |
| IPCA Laboratories Limited | 8.55% | ₹ 259.36 | Pharmaceuticals |
| Cipla Limited | 8.06% | ₹ 244.49 | Pharmaceuticals |
| Globus Medical Inc | 7.69% | ₹ 233.39 | Others |
| Laurus Labs Limited | 6.50% | ₹ 197.15 | Pharmaceuticals |
| Illumina Inc | 6.47% | ₹ 196.16 | Others |
| Sai Life Sciences Limited | 5.90% | ₹ 178.91 | Pharmaceuticals |
| Gland Pharma Limited | 5.53% | ₹ 167.76 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 5.02% | ₹ 152.34 | Hospitals & Medical Services |
| Alembic Pharmaceuticals Limited | 3.35% | ₹ 101.57 | Pharmaceuticals |
| Pfizer Limited | 3.35% | ₹ 101.57 | Pharmaceuticals |
| Vijaya Diagnostic Centre Limited | 3.10% | ₹ 93.97 | Hospitals & Medical Services |
| Cohance Lifesciences Limited | 3.04% | ₹ 92.12 | Pharmaceuticals |
| Kovai Medical Center and Hospital Limited | 2.88% | ₹ 87.32 | Hospitals & Medical Services |
| Intuitive Surgical Inc | 2.83% | ₹ 85.95 | Others |
| Procter & Gamble Health Limited | 2.57% | ₹ 78.06 | Pharmaceuticals |
| Indoco Remedies Limited | 2.16% | ₹ 65.41 | Pharmaceuticals |
| Concord Biotech Limited | 2.00% | ₹ 60.63 | Pharmaceuticals |
| Emcure Pharmaceuticals Limited | 1.86% | ₹ 56.49 | Pharmaceuticals |
| ICICI Lombard General Insurance Company Limited | 1.51% | ₹ 45.90 | Finance - Non Life Insurance |
| Nephrocare Health Services Limited | 1.24% | ₹ 37.71 | Hospitals & Medical Services |
| TREPS / Reverse Repo Investments | 1.14% | ₹ 34.73 | Others |
| Abbott Laboratories | 1.10% | ₹ 33.44 | Others |
| Aarti Drugs Limited | 1.03% | ₹ 31.27 | Pharmaceuticals |
| Unichem Laboratories Limited | 0.97% | ₹ 29.50 | Pharmaceuticals |
| Global X Funds - Global X Genomics & Biotechnology ETF | 0.88% | ₹ 26.55 | Others |
| Alkem Laboratories Limited | 0.69% | ₹ 21.05 | Pharmaceuticals |
| Corona Remedies Limited | 0.61% | ₹ 18.57 | Pharmaceuticals |
| Medplus Health Services Limited | 0.54% | ₹ 16.28 | Pharmaceuticals |
| Jupiter Life Line Hospitals Limited | 0.39% | ₹ 11.88 | Hospitals & Medical Services |
| Laxmi Dental Limited | 0.18% | ₹ 5.40 | Medical Equipment & Accessories |
| Grail Inc | 0.14% | ₹ 4.23 | Others |
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | 4.70% | 9.75% | 12.61% | 22.65% |
| Category returns | 1.21% | 5.68% | 6.27% | 22.53% |
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies.
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity fund - Direct Plan
Sector
Direct
|
₹39.90 | 202.92% | 342.40% | 0.00% | ₹1,256 | 0.85% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
Nippon India Taiwan Equity Fund
Sector
Regular
|
₹37.37 | 198.79% | 324.40% | 0.00% | ₹1,256 | 2.15% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund - Direct Plan
Sector
Direct
|
₹30.47 | 18.71% | 201.11% | 0.00% | ₹9,724 | 0.83% |
Very High
|
|
HDFC Defence Fund
Sector
Regular
|
₹29.45 | 17.51% | 191.18% | 0.00% | ₹9,724 | 1.75% |
Very High
|
What is the current NAV of DSP Healthcare Fund - Direct Plan Growth?
What is the fund size (AUM) of DSP Healthcare Fund - Direct Plan Growth?
What are the historical returns of DSP Healthcare Fund - Direct Plan Growth?
What is the risk level of DSP Healthcare Fund - Direct Plan Growth?
What is the minimum investment amount for DSP Healthcare Fund - Direct Plan Growth?
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article